According to the latest report by IMARC Group, titled “Proteinase K Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global proteinase K market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the global proteinase K market to grow at a CAGR of around 5% during 2021-2026.

Proteinase K refers to a serine alkaline protease that is extensively used in protein digest. It is also utilized in molecular biology to separate contamination from nuclear acid preparations. Moreover, as proteinase K helps in the elimination of endotoxins bound to cationic patients, such as lysozyme and ribonuclease A, determination of enzyme localization on membranes, and digestion of proteins from brain tissue samples, its demand is accelerating around the globe.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request Free Sample Report:

Market Trends:

The rising utilization of proteinase K for nucleic acid purification, improved cloning efficiency and tissue digestion is primarily driving the market growth. Furthermore, the growing prevalence of infectious diseases and the escalating adoption of proteinase K in diagnosing these diseases are also propelling the market growth. Additionally, proteinase K finds extensive usage in the treatment of paraffin-embedded sections of tissues during antibody labeling and isolation of mitochondria from hepatic cells. Moreover, it is also adopted during the polymerase chain reaction (PCR) distillation for a broad range of in-vitro diagnostics (IVD) procedures. Besides this, the outbreak of COVID-19 is exponentially augmenting the market growth as proteinase K is working in the pre-treatment to detect the SARS-CoV-2 in samples collected without the need for RNA extraction, which is expected to further bolster the market growth in the coming years.

Explore Full Report with TOC & List of Figure:

Key Market Segmentation:          

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

  • Advanced Enzymes Technologies Ltd.
  • American Laboratories
  • Amicogen Inc.
  • BBI Solutions
  • Biocatalysts Ltd.
  • Codexis Inc.
  • Dyadic International Inc.
  • Hoffmann-La Roche Ltd. (Roche Ag)
  • Merck KGaA
  • Qiagen N.V.
  • Thermo Fisher Scientific Inc.

Breakup by Therapeutic Area:

  • Infectious Diseases
  • Diabetes
  • Oncology
  • Cardiology
  • Nephrology
  • Autoimmune Diseases
  • Neurology
  • Others

Breakup by Type:

  • Natural
  • Recombinant

Breakup by Form:

  • Powder
  • Liquid

Breakup by End User:

  • Pharmaceutical Companies
  • Academic and Research Centers
  • Contract Research Organizations

Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the Report:

  • Market Performance (2015-2020)
  • Market Outlook (2021-2026)
  • COVID-19 Impact on the Market
  • Porter’s Five Forces Analysis
  • Historical, Current and Future Market Trends
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Structure of the Market
  • Value Chain Analysis
  • Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Latest Research Reports by IMARC Group:

By kamal

Leave a Reply

Your email address will not be published. Required fields are marked *